lapachol has been researched along with shikonin in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Danilenko, NV; Karpenko, AS; Khlebnikov, AI; Kirpotina, LN; Levandovskiy, IA; Quinn, MT; Schepetkin, IA; Shibinska, MO | 1 |
Ding, H; Dong, H; Hou, Z; Luo, C; Min, W; Qi, L; Wang, L; Xie, S; Yang, P; Yuan, K; Zhang, F | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Bao, JL; Chen, XP; Huang, MQ; Lu, JJ; Wang, YT; Wu, GS; Xu, WS | 1 |
Hato, T; Lakhter, AJ; Mahanta, S; Naidu, SR; Paul, S; Shankar Babu, M | 1 |
1 review(s) available for lapachol and shikonin
Article | Year |
---|---|
Quinones derived from plant secondary metabolites as anti-cancer agents.
Topics: Anthraquinones; Antineoplastic Agents, Phytogenic; Benzoquinones; Cell Line, Tumor; Cell Survival; Humans; Naphthoquinones; Neoplasms; Plant Extracts | 2013 |
4 other study(ies) available for lapachol and shikonin
Article | Year |
---|---|
Synthesis, anticancer activity, and molecular modeling of 1,4-naphthoquinones that inhibit MKK7 and Cdc25.
Topics: Antineoplastic Agents; cdc25 Phosphatases; Cell Line, Tumor; Cell Survival; Enzyme Inhibitors; Humans; MAP Kinase Kinase 7; Models, Molecular; Molecular Docking Simulation; Naphthoquinones | 2019 |
Computational discovery and biological evaluation of novel inhibitors targeting histone-lysine N-methyltransferase SET7.
Topics: Antineoplastic Agents; Catalytic Domain; Cell Line, Tumor; Cell Survival; Computational Chemistry; Computer Simulation; Drug Discovery; Escherichia coli; Histone-Lysine N-Methyltransferase; Humans; Molecular Structure; Protein Binding; Protein Conformation; Structure-Activity Relationship | 2020 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Lapachol inhibits glycolysis in cancer cells by targeting pyruvate kinase M2.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Glycolysis; Humans; Melanoma; Mitochondria; Models, Molecular; Naphthoquinones; Oxygen Consumption; Pyruvate Kinase | 2018 |